Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
03/1999
03/31/1999CN1212695A 4-amino pyrimidine derivates, medicament containing these compounds, their use
03/31/1999CN1212694A Pyrimido [5,4-D] pyrimidines, medicaments containing these compounds, their use and process for their production
03/31/1999CN1212689A Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds
03/31/1999CN1212625A Caffeine and clemastine for treating respiratory disorders
03/31/1999CN1212620A Mercapto derivatives as inhibitors of cyclooxygenases
03/31/1999CN1042730C Method for preparing pyrazolopyridine compound
03/30/1999US5889178 N-(2,2-diphenylethyl)-derivatives
03/30/1999US5889171 Genetic engineered polypeptide
03/30/1999US5889160 Human IL-2 receptor γ-chain molecule antibody
03/30/1999US5889153 Protein or polypeptide, method for producing the same and intermediate compound therefor
03/30/1999US5889143 Evaluation and treatment of patients with progressive immunosuppression
03/30/1999US5889049 Use of terpene compounds for reduced release of arachidonic acid and of inflammation mediators
03/30/1999US5889042 Method of treating diseases and conditions with estrogen agonists and antagonists
03/30/1999US5889037 Prevention, therapy tissue damage from lipid peroxidation
03/30/1999US5889014 Heterocyclic compounds for inhibiting phosphodiesterase IV
03/30/1999US5888969 Crohn*s disease
03/30/1999US5888965 Method of stimulating bone marrow regeneration
03/30/1999US5888775 Peptide synthesis and purification by fusion to penI protein or precipitation effective portion thereof
03/30/1999US5888773 Genetic engineered protein
03/30/1999US5888750 Method of recovering shiga-like toxins and vaccines comprising inactivated shiga-like toxin
03/30/1999US5888519 Vaccine
03/30/1999US5888516 Genetic engineered protein
03/30/1999US5888512 Human leukocyte antigen peptides which can inhibit cytotoxic t-lymphocyte activity
03/30/1999US5888508 Monoclonal antibodies against leukocyte adhesion receptor β-chain methods of producing these antibodies and use therefore
03/30/1999CA2053903C Heterocyclic n-oxide derivatives of substituted benzo¬5,6|cycloheptapyridines, compositions and methods of use
03/30/1999CA2047216C 9-substituted-8-unsubstituted-9-deazaguanines
03/30/1999CA1340472C Universal t-cell epitope derived from p. faciparum circumsporosoite protein
03/25/1999WO1999014353A2 Intrabody-mediated control of immune reactions
03/25/1999WO1999014340A1 Human prl-1 phosphatase
03/25/1999WO1999014322A2 Allelic variant of human stat3
03/25/1999WO1999014242A2 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
03/25/1999WO1999014236A1 Recombinant mhc molecules useful for manipulation of antigen-specific t-cells
03/25/1999WO1999013915A1 Method of delivering genes to antigen presenting cells of the skin
03/25/1999WO1999013914A1 Pharmaceutical compositions containing plasma protein
03/25/1999WO1999013907A2 Methods to improve immunogenicity of antigens and specificity of antibodies
03/25/1999WO1999013904A1 T-cell vaccination for the treatment of multiple sclerosis
03/25/1999WO1999013896A1 Attenuated vif dna immunization cassettes for genetic vaccines
03/25/1999WO1999013885A1 Modulation of immune responses
03/25/1999WO1999013818A2 Membrane virus host range mutations and their uses as vaccine substrates
03/25/1999WO1999000002A3 Cyclosporin-containing microemulsion preconcentrate composition
03/25/1999WO1998054225A3 Human-cd28 specific monoclonal antibodies for antigen non-specific activation of t-lymphocytes
03/25/1999WO1998051665A3 Novel macrocyclic compounds as metalloprotease inhibitors
03/25/1999WO1998050032A9 BETA-LACTAM INHIBITORS OF CoA-IT
03/25/1999DE19742014A1 Use of new and known tetracyclene compounds as phospholipase inhibitors
03/25/1999CA2304373A1 T-cell vaccination for the treatment of multiple sclerosis
03/25/1999CA2304208A1 Intrabody-mediated control of immune reactions
03/25/1999CA2304125A1 Attenuated vif dna immunization cassettes for genetic vaccines
03/25/1999CA2304119A1 Modulation of immune responses
03/25/1999CA2303775A1 Methods to improve immunogenicity of antigens and specificity of antibodies
03/25/1999CA2303227A1 Human prl-1 phosphatase
03/25/1999CA2302782A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
03/25/1999CA2302316A1 Method of delivering genes to antigen presenting cells of the skin
03/24/1999EP0903353A1 Imidazolidine derivates, their preparation and use, and pharmaceutical compositions containing them
03/24/1999EP0903349A2 CCR-3 receptor antagonists
03/24/1999EP0903348A1 Epothilone derivatives, preparation and utilization
03/24/1999EP0903345A1 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamid
03/24/1999EP0903151A1 Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms
03/24/1999EP0903150A1 Regulation of immunoglobulin production by interleukin-9
03/24/1999EP0902837A1 Tailless nuclear hormone receptor (tlx receptor)
03/24/1999EP0902789A1 Androstene derivatives
03/24/1999EP0902782A1 Urea derivatives as inhibitors of impdh enzyme
03/24/1999EP0745063B1 Substituted biphenyl derivatives as phosphodiesterase inhibitors
03/24/1999EP0667855B1 Substituted arylalkynyl- and heteroarylalkynyl-n-hydroxyurea inhibitors of leukotriene biosynthesis
03/24/1999CN1211926A Pharmaceutical composition for immunomodulation based on peptides and adjuvants
03/24/1999CN1211925A Use of ginkgo biloba extracts for preparation of pharmaceutical compositions and method of cosmetic treatment using ginkgo biloba extract
03/24/1999CN1211572A Cyclic amine derivatives-CCR-3 receptor antagonists
03/23/1999US5886145 Isolated nucleic acid molecules, peptides which form complexes with MHC molecule HLA-A2 and uses thereof
03/23/1999US5886044 IL-8 receptor antagonists
03/23/1999US5886036 Treating hiv infections
03/23/1999US5886020 3-(4'-dimethylaminobenzylidenyl)-2-indolinone and analogues thereof for the treatment of disease
03/23/1999US5886009 Quinuclidine derivative as a substance P antagonist
03/23/1999US5885962 Stem cell factor analog compositions and method
03/23/1999US5885805 gbpA
03/23/1999US5885800 DNA encoding tumor necrosis related receptor, TR4
03/23/1999US5885796 CTLA4 receptor and uses thereof
03/23/1999US5885768 Immunogenic peptides derived from the orf1, orf2, and orf3 regions of hepatitis e virus (hev), diagnostic reagents containing the peptide antigens, vaccine compositions containing the antigens, antibodies
03/23/1999US5885588 Schizophrenia associated with an autoimmune reaction initiated by an infection can be treated by injection comprising dead cell of mycobacterium vaccae
03/23/1999US5885579 CTLA4 receptor and uses thereof
03/23/1999US5885576 Vaccines and methods for preventing and treating fescue toxicosis in herbivores
03/23/1999US5885573 Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies
03/23/1999US5885570 Induction of tolerance with modified immunogens
03/23/1999CA2093513C Methods and compositions for suppressing allograft rejection in mammals
03/23/1999CA2092794C Naphthylalkylamines, process for their preparation and pharmaceutical compositions that contain them
03/23/1999CA2008771C Pyridinium nitrate, its production and use
03/23/1999CA1340463C Alkanophenones
03/18/1999WO1999013095A2 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses
03/18/1999WO1999013055A1 Human sigma receptor
03/18/1999WO1999012968A2 Chemokine peptides, variants, derivatives and analogs, their use in methods to inhibit or augment an inflammatory response
03/18/1999WO1999012964A2 Kay - a novel immune system protein
03/18/1999WO1999012944A2 SYNTHETIC DIVALENT sLex CONTAINING POLYLACTOSAMINES AND METHODS FOR USE
03/18/1999WO1999012915A1 Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals
03/18/1999WO1999012566A1 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF
03/18/1999WO1999012565A1 Vaccines
03/18/1999WO1999012562A1 Synthetic antigens for cd1-restricted immune responses
03/18/1999WO1999012559A1 Inhibition of apoptotis using prosaposin receptor agonists
03/18/1999WO1999012523A1 Modulation of drug loading in multivesicular liposomes
03/18/1999WO1998056909A3 Secreted proteins and polynucleotides encoding them
03/18/1999CA2304108A1 Inhibition of apoptotis using prosaposin receptor agonists
03/18/1999CA2303479A1 Human sigma receptor
03/18/1999CA2303440A1 Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals
1 ... 983 984 985 986 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 1001 1002 1003 ... 1172